Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

461
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
461
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

569
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
569
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

295
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
295
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

455
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
455
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

450
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
450
Censoring Survival Data01:09

Censoring Survival Data

418
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
418

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The performance of latent class analysis for clustering multiple long-term conditions is robust to the impact of high-prevalence conditions.

Journal of clinical epidemiology·2026
Same author

The predictive power of first recruits to commercial trial performance.

BMC medical research methodology·2026
Same author

Adaptive trials in low back pain and osteoarthritis: How common are they and when should they be used? A systematic review from ClinicalTrials.gov.

Osteoarthritis and cartilage open·2026
Same author

Authors' Reply: Posttrial Withdrawal Ethics in the Healthy Ageing Ecosystem for People With Dementia (HAAL) Study.

JMIR research protocols·2026
Same author

Applying a hypothetical strategy to the intercurrent event of non-adherence with the parametric g-formula: a post hoc secondary analysis of the MET-PREVENT randomised controlled trial.

Trials·2026
Same author

Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gaps.

Trials·2026

Related Experiment Video

Updated: Dec 10, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K

Efficient analysis of time-to-event endpoints when the event involves a continuous variable crossing a threshold.

Chien-Ju Lin1, James M S Wason1,2

  • 1Medical Research Council Biostatistics Unit, University of Cambridge, UK.

Journal of Statistical Planning and Inference
|September 5, 2020
PubMed
Summary
This summary is machine-generated.

This study introduces a novel statistical method for analyzing patient event times in clinical trials. By incorporating continuous measurements alongside binary outcomes, the new approach enhances the precision of survival analyses for time-to-event endpoints.

Keywords:
Longitudinal modelPhase II cancer trialProgression-free survival

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

446
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Related Experiment Videos

Last Updated: Dec 10, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.6K
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

446
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K

Area of Science:

  • Biostatistics
  • Clinical Trial Design
  • Survival Analysis

Background:

  • Time-to-event endpoints are crucial in clinical trials, often defined by complex event criteria.
  • Current methods typically simplify these criteria into binary variables, potentially losing valuable information.
  • Continuous measurements within event definitions are often underutilized in standard survival analyses.

Purpose of the Study:

  • To propose a novel statistical method that leverages both continuous and binary components of event criteria for improved survival analysis.
  • To enhance the precision of time-to-event endpoint analyses by incorporating richer data.
  • To develop a method for constructing survival curves and calculating confidence intervals using joint modeling.

Main Methods:

  • Joint modeling of continuous and binary components defining clinical trial event criteria.
  • Construction of survival curves that integrate information from both data types.
  • Computation of confidence intervals for key survival metrics like median and mean event times.
  • Validation through simulations and real-world data from cancer and renal disease studies.

Main Results:

  • The proposed joint modeling approach improves the precision of survival analyses compared to traditional methods.
  • Demonstrated utility in analyzing complex time-to-event endpoints in clinical research.
  • Successfully computed confidence intervals for median and mean event times.
  • Validated through simulations and application to diverse clinical datasets.

Conclusions:

  • Joint modeling of continuous and binary event components offers a more precise and informative approach to survival analysis.
  • This method enhances the statistical power and accuracy of clinical trial endpoint evaluation.
  • The findings have significant implications for designing and analyzing future clinical trials, particularly those with composite endpoints.